Literature DB >> 16751794

Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.

Ying Zhu1, Jian Yao, Yiman Meng, Ayumi Kasai, Nobuhiko Hiramatsu, Kunihiro Hayakawa, Takashi Miida, Masayuki Takeda, Masahiko Okada, Masanori Kitamura.   

Abstract

1. Phosphodiesterases (PDEs) are critically implicated in the regulation of mesangial cell function, but profile of functional PDEs in mesangial cells is still unclear. In this study, we investigated roles of individual PDEs in the regulation of mesangial cell behavior by the cAMP pathway. 2. Reporter mesangial cells that express secreted alkaline phosphatase (SEAP) under the control of the cAMP response element (CRE) were exposed to selective PDE inhibitors in the presence or absence of cAMP, and activity of CRE, expression of CRE-regulated protein, mitogenesis and cell survival were examined. 3. Exposure of reporter cells to cAMP-elevating agents resulted in time- and concentration-dependent activation of CRE. Treatment of the cells with any PDE inhibitors alone did not induce CRE activation. Under stimulation with 8-bromo-cAMP or 8-bromo-cGMP, however, inhibitors of PDE2, PDE3, PDE4 and PDE5 enhanced activation of CRE. Inhibition of PDE1 or PDE6 did not affect the CRE activation. 4. Among different combinations tested, only inhibitors of PDE3 and PDE4 cooperatively increased the level of intracellular cAMP, activity of protein kinase A, activation of CRE, and CRE-regulated protein, connexin43. 5. Concomitant inhibition of PDE3 and PDE4 attenuated mitogen-induced activation of extracellular signal-regulated kinases and cell proliferation. Under serum deprivation, combinational inhibition of PDE3 and PDE4 exclusively caused activation of caspase-3 and apoptosis. 6. The present data elucidated that PDE3 and PDE4 play critical roles in the regulation of mesangial cell function. PDE3 and PDE4 were identified as the novel, antiapoptotic machinery that supports survival of mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751794      PMCID: PMC1617067          DOI: 10.1038/sj.bjp.0706785

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

Review 1.  Connexins, connexons, and intercellular communication.

Authors:  D A Goodenough; J A Goliger; D L Paul
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 2.  Tailoring cAMP-signalling responses through isoform multiplicity.

Authors:  M D Houslay; G Milligan
Journal:  Trends Biochem Sci       Date:  1997-06       Impact factor: 13.807

Review 3.  The gap junction communication channel.

Authors:  N M Kumar; N B Gilula
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

4.  cAMP promotes gap junctional coupling in T84 cells.

Authors:  M Chanson; M M White; S S Garber
Journal:  Am J Physiol       Date:  1996-08

5.  Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.

Authors:  D P Begany; J A Carcillo; W A Herzer; Z Mi; E K Jackson
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

6.  Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.

Authors:  C C Chini; J P Grande; E N Chini; T P Dousa
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

7.  Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.

Authors:  Y Tsuboi; S J Shankland; J P Grande; H J Walker; R J Johnson; T P Dousa
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

8.  Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells.

Authors:  Jian Yao; Masanori Kitamura; Ying Zhu; Yiman Meng; Ayumi Kasai; Nobuhiko Hiramatsu; Tetsuo Morioka; Masayuki Takeda; Takashi Oite
Journal:  Am J Physiol Renal Physiol       Date:  2005-11-01

9.  Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.

Authors:  P A Craven; R K Studer; J Felder; S Phillips; F R DeRubertis
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

10.  Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .

Authors:  M Kitamura; T Sütö; T Yokoo; F Shimizu; L G Fine
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

View more
  9 in total

Review 1.  Pathophysiological roles of gap junction in glomerular mesangial cells.

Authors:  Jian Yao; Ying Zhu; Tetsuo Morioka; Takashi Oite; Masanori Kitamura
Journal:  J Membr Biol       Date:  2007-07-11       Impact factor: 1.843

2.  Phosphodiesterase-5 gene (PDE5A) polymorphisms are associated with progression of childhood IgA nephropathy.

Authors:  Won-Ho Hahn; Jin-Soon Suh; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2010-06-20       Impact factor: 3.714

3.  Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents.

Authors:  Tiffany A Kolniak; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2011-01-21       Impact factor: 3.467

4.  Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

Authors:  J Yao; Y Zhu; W Sun; N Sawada; N Hiramatsu; M Takeda; M Kitamura
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

5.  Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth.

Authors:  Raghvendra K Dubey; Marinella Rosselli; Delbert G Gillespie; Zaichuan Mi; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2010-03-01       Impact factor: 4.030

Review 6.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

7.  Multiplexing bioluminescent and fluorescent reporters to monitor live cells.

Authors:  Michael Haugwitz; Omar Nourzaie; Tatiana Garachtchenko; Lanrong Hu; Suvarna Gandlur; Cathy Olsen; Andrew Farmer; Grigoriy Chaga; Hiroaki Sagawa
Journal:  Curr Chem Genomics       Date:  2008-02-25

8.  Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation.

Authors:  Kai Li; Jian Yao; Yuan Chi; Norifumi Sawada; Isao Araki; Masanori Kitamura; Masayuki Takeda
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

9.  Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.

Authors:  Tsai-Hsien Hung; Sheng-Chi Hsu; Ching-Yi Cheng; Kong-Bung Choo; Ching-Ping Tseng; Tse-Ching Chen; Ying-Wei Lan; Tsung-Teng Huang; Hsin-Chih Lai; Chuan-Mu Chen; Kowit-Yu Chong
Journal:  Oncotarget       Date:  2014-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.